TCL Archive FDA approves a new cancer drug, Vidaza, and two sNDAs, without going to ODAC. A date with ODAC may signal a weak case for drug approval, recent approval data indicate. May 28, 2004
TCL Archive Another Feasibility Study For Women’s Wealth Trial? Yes And No; It’s ‘Class Of 84’s” Adieu December 14, 1990
TCL Archive Did ACS Flip-Flop On Stem Cell Research? Society Says No, Patient Coalition Says Yes September 10, 1999
